welcome
Working for the people to improve healthcare

CIBBIM-Nanomedicine Director

Dr. Simó Schwartz Jr


Nanomedicine and Advanced Therapies as translational sciences have the ultimate goal to provide cost effective novel therapies and diagnostics. As key enable technologies these new options will cause profound changes in healthcare, making feasible more personalized, predictive, preventive, and regenerative medicine.

PRECLINICAL SERVICES

This platform offers standard in vitro experimentation procedures for the functional validation of candidate genes and biomarkers, and for the efficacy and toxicological evaluation of new drugs, biomaterials and biomarkers.
Read more

At the moment, the platform offers standardin vivo experimentation procedures for the evaluation of new therapeutic targets, nanotherapies and biomarkers in the field of oncology and rare diseases.
Read more

Latest
news

News

CaixaImpulse selects a VHIR project to combat multiresistant infections

CaixaImpulse selects a VHIR project to combat multiresistant infections

El projecte ThermoShot™-FlashShot™: Nova tecnologia per combatre les infeccions multiresistents o les produïdes per dispositius mèdics que produeixen biopel·lícules...

Read more
NANOMEDICINE AND FUTURE, explained by Simó Schwartz, Director of U20 of NANBIOSIS

NANOMEDICINE AND FUTURE, explained by Simó Schwartz, Director of U20 of NANBIOSIS

NANBIOSIS-U20 Scientific Director, Simó Schwartz, speaks about Nanomedicine in an interview publish in http://www.quimicaysociedad.org. NANBIOSIS is an Singular...

Read more
Nanomedicine & Bioengineering

Publications

Diverse Applications of Nanomedicine.

Pelaz B, Alexiou C, Alvarez-Puebla RA, Alves F, Andrews AM, Ashraf S, Balogh LP, Ballerini L, Bestetti A, Brendel C, Bosi S, Carril M, Chan WC, Chen C, Chen X, Chen...

Read more